Cargando…
Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis
Background: In recent years, various biomarkers of ulcerative colitis (UC) have emerged; however, few studies have simultaneously examined the utility of multiple biomarkers for monitoring disease activity. Additionally, serum leucine-rich alpha-2 glycoprotein (LRG), a new biomarker, may show a blun...
Autores principales: | Tatsumi, Yoshihiro, Kakimoto, Kazuki, Hara, Azusa, Mizuta, Noboru, Numa, Keijiro, Kinoshita, Naohiko, Nakazawa, Kei, Koshiba, Ryoji, Hirata, Yuki, Ota, Kazuhiro, Miyazaki, Takako, Nakamura, Shiro, Sakagami, Kayoko, Arimitsu, Shoko, Ito, Hiroaki, Nishikawa, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672609/ https://www.ncbi.nlm.nih.gov/pubmed/38002777 http://dx.doi.org/10.3390/jcm12227165 |
Ejemplares similares
-
Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis
por: Numa, Keijiro, et al.
Publicado: (2023) -
Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis
por: Kinoshita, Naohiko, et al.
Publicado: (2022) -
Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative Colitis
por: Nakata, Satoshi, et al.
Publicado: (2022) -
Therapeutic Drug Monitoring of Golimumab for the Prediction of Long-Term Clinical Remission in Patients with Ulcerative Colitis
por: Tawa, Hideki, et al.
Publicado: (2022) -
Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition
por: Kawasaki, Yuka, et al.
Publicado: (2023)